ATE328899T1 - Zellkernlokalisierendes protein für beta-catenin - Google Patents

Zellkernlokalisierendes protein für beta-catenin

Info

Publication number
ATE328899T1
ATE328899T1 AT01970148T AT01970148T ATE328899T1 AT E328899 T1 ATE328899 T1 AT E328899T1 AT 01970148 T AT01970148 T AT 01970148T AT 01970148 T AT01970148 T AT 01970148T AT E328899 T1 ATE328899 T1 AT E328899T1
Authority
AT
Austria
Prior art keywords
beta
catenin
protein
nuclear localizing
cell nuclear
Prior art date
Application number
AT01970148T
Other languages
English (en)
Inventor
Tetsu Akiyama
Shungo Adachi
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Application granted granted Critical
Publication of ATE328899T1 publication Critical patent/ATE328899T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57595—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT01970148T 2000-09-22 2001-09-19 Zellkernlokalisierendes protein für beta-catenin ATE328899T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000287876 2000-09-22

Publications (1)

Publication Number Publication Date
ATE328899T1 true ATE328899T1 (de) 2006-06-15

Family

ID=18771553

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01970148T ATE328899T1 (de) 2000-09-22 2001-09-19 Zellkernlokalisierendes protein für beta-catenin

Country Status (10)

Country Link
US (1) US7358348B2 (de)
EP (1) EP1323732B9 (de)
JP (1) JPWO2002024738A1 (de)
KR (1) KR20030045083A (de)
AT (1) ATE328899T1 (de)
AU (1) AU2001290242A1 (de)
CA (1) CA2423108A1 (de)
DE (1) DE60120440T2 (de)
ES (1) ES2264450T3 (de)
WO (1) WO2002024738A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7049290B2 (en) 2000-07-28 2006-05-23 Universität Zürich Essential downstream component of the wingless signaling pathway and therapeutic and diagnostic applications based thereon
KR100508815B1 (ko) * 2003-01-08 2005-08-19 국립암센터 β-카테닌 올리고뉴클레오티드 마이크로칩 및 이를이용하여 β-카테닌 유전자의 돌연변이를 검사하는 방법
WO2007022346A2 (en) * 2005-08-15 2007-02-22 The Regents Of The University Of California Cellular function underlying bone micro-structure characteristic of type 2 diabetes
KR101718507B1 (ko) * 2012-07-02 2017-03-22 사회복지법인 삼성생명공익재단 암 치료제 스크리닝 방법
CA3120699A1 (en) 2018-11-21 2020-05-28 Endomet Biosciences, Inc. Compositions and methods for treating endometriosis
KR102084953B1 (ko) 2019-09-18 2020-05-26 문동석 배기가스 정화용 집진 장치
KR102454946B1 (ko) 2021-09-30 2022-10-17 문동석 배기 가스 미세먼지 집진장치
CN115124619B (zh) * 2022-06-24 2023-05-05 广东齐美医药生物科技集团有限公司 临床血液免疫细胞的制备方法及其应用
WO2025104494A2 (en) * 2023-11-13 2025-05-22 Versameb Ag Compositions and methods for modulating protein interactions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658784A (en) * 1994-04-14 1997-08-19 Dana-Farber Cancer Institute, Inc. Nucleic acid encoding transcription factor p300 and uses of p300
WO2000058473A2 (en) 1999-03-31 2000-10-05 Curagen Corporation Nucleic acids including open reading frames encoding polypeptides; 'orfx'
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
WO2001092523A2 (en) 2000-05-30 2001-12-06 Curagen Corporation Human polynucleotides and polypeptides encoded thereby
US7049290B2 (en) * 2000-07-28 2006-05-23 Universität Zürich Essential downstream component of the wingless signaling pathway and therapeutic and diagnostic applications based thereon

Also Published As

Publication number Publication date
WO2002024738A1 (fr) 2002-03-28
US20040073001A1 (en) 2004-04-15
EP1323732B1 (de) 2006-06-07
EP1323732B9 (de) 2008-02-27
EP1323732A1 (de) 2003-07-02
DE60120440T2 (de) 2007-01-04
KR20030045083A (ko) 2003-06-09
AU2001290242A1 (en) 2002-04-02
DE60120440D1 (de) 2006-07-20
ES2264450T3 (es) 2007-01-01
JPWO2002024738A1 (ja) 2004-01-29
CA2423108A1 (en) 2003-03-19
EP1323732A4 (de) 2004-08-04
US7358348B2 (en) 2008-04-15

Similar Documents

Publication Publication Date Title
MXPA04000062A (es) Miembros de drenaje extensibles para conectar a tierra la proteccion por interferencia electromagnetica/interferencia por radiofrecuencia.
IL153052A0 (en) Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
AR030236A1 (es) Moléculas similares a il-17 y usos de las mismas
EA200000759A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
TR200103560T2 (tr) Göğüs kanserinin teşhis ve tedavisi için bileşimler ve bunların kullanımı
PL374326A1 (pl) Mikroorganizmy i komórki do diagnozy i terapii przeciwrakowej
CY1110256T1 (el) Διαμεμβρανικο αντιγονο λεκτινης τυπου c εκφραζομενο σε καρκινο στον προστατη ανθρωπου και χρησεις αυτου
BR0112644A (pt) Método de identificar marcadores de câncer e usos destes no diagnóstico do câncer
IS6491A (is) Pteridínefnasambönd til meðhöndlunar á sóríasis
BR0110091A (pt) Composições e processos para terapia e diagnóstico de câncer de mama
ATE328899T1 (de) Zellkernlokalisierendes protein für beta-catenin
BRPI0409359A (pt) análogos quiméricos de somatostatina-dopamina
AR030554A1 (es) Moleculas similares a receptores il-17 y usos de las mismas
WO2004025303A3 (en) Isoprostanes as markers of psychological stress in humans
ATE234858T1 (de) Isolierte und verkürzte nukleinsäuremoleküle kodierend für gage-tumorabstossungsantigen
PL2089433T3 (pl) Terapia ukierunkowana na katepsynę S
IL212653A (en) Large Ishmania polypeptides and their encoded polynucleotides and vaccines and diagnostic uses thereof
DE60014064D1 (de) Einetenascin-c isoform als marker für neoplasmen
CY1106363T1 (el) Χρηση του ενepγοποιημενου παραγοντα πηξης vii για την αγωγη των επαγομενων απο θρομβολυτικη θepαπεια μειζονων αιμορραγιων
BR0009573A (pt) Composições e métodos para o tratamento e diagnose do câncer de mama
BR0207327A (pt) Amino derivados de biotina e seus conjugados com agentes quelantes macrocìclicos
ATE445842T1 (de) Nachweis spezifischer nitrierter marker
ATE282697T1 (de) Vektorkonstrukte zur gentherapeutisch vermittelten radionuklid-therapie entdifferenzierter und medullärer schilddrüsen- karzinome sowie nicht-thyreoidaler tumore und ihrer metastasen
BR0308180A (pt) protéinas de superfìcie de leptospira
WO2002038803A3 (de) Neue marker für die diagnose und therapie von tumoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties